93 results
Page 4 of 5
8-K
EX-99.1
fc1bpvufser7xcepjw
16 Sep 20
Other Events
4:07pm
8-K
EX-99.1
8cm9f junh5oyf3syru
11 Aug 20
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:05pm
424B4
3npjnvpj s0y
8 Jul 20
Prospectus supplement with pricing info
4:35pm
8-K
EX-99.2
gexxdzyj v3e
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
8-K
EX-99.1
v7v9kdiz33deb73
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
DRS
5cb8o
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.56
rx0wt5zzucbwsm le
23 Jun 20
Draft registration statement
12:00am
8-K
EX-99.1
3et1spm0w jcc4m
19 Jun 20
Patent License Agreement
5:26pm
8-K
faeodpsnqrf2
19 Jun 20
Patent License Agreement
5:26pm
8-K
18r3f8w hro05um03kh6
15 Jun 20
Entry into a Material Definitive Agreement
4:13pm
8-K
EX-99.1
o6j g72alvp7qyo
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
8-K
p2rmxn7h4imy16a
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
8-K
EX-99.1
sgidgxjrmqnpm7 kff
12 May 20
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:05pm
DEFA14A
z03c8s5h9xr
8 May 20
Additional proxy soliciting materials
4:10pm
8-K
EX-99.1
3tbqsqh5
10 Apr 20
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture ofSARS-COV-2 Antibodies for Potential COVID-19 Treatment
8:01am
8-K
ykw4z2wtjg92flf9c9y
10 Apr 20
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture ofSARS-COV-2 Antibodies for Potential COVID-19 Treatment
8:01am